Yunlong Shan1, Mengying Zhang2, Enxiang Tao2

  • 1Key Laboratory of Drug Metabolism and Pharmacokinetics, Haihe Laboratory of Cell Ecosystem, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China. immunometabolism@163.com.

概括

介质细胞干细胞/细胞 (MSC) 疗法显示出有前途,但面临着挑战. 了解MSC的药理动力学和开发更好的追踪方法是提高临床疗效和商业化的关键.